scholarly journals Combination therapy with levofloxacin and cefepime to treat severe respiratory infection due to Aeromonas caviae after a near‐drowning accident in river water

2021 ◽  
Vol 8 (1) ◽  
Author(s):  
Atsuo Maeda ◽  
Yasuhiro Nakajima ◽  
Kaoru Yanagisawa ◽  
Tatsuya Sugimoto ◽  
Kohei Harano ◽  
...  
Keyword(s):  
Combination Therapy ◽  
River Water ◽  
Respiratory Infection ◽  
Near Drowning ◽  
Aeromonas Caviae ◽  
Severe Respiratory Infection

scholarly journals The Role of Preventive Measures or a Previously Immunized Population: A Pilot Study on Coronavirus Disease-19 in Syria

2020 ◽  
Vol 9 (3) ◽  
pp. 101-104
Author(s):  
Samaher Almousa ◽  
Ammar Suleiman ◽  
Samer Mohsen
Keyword(s):  
Respiratory Infection ◽  
Respiratory Infections ◽  
Previous History ◽  
Preventive Measure ◽  
Immunoglobulin M ◽  
Medical Community ◽  
Study Materials ◽  
Two Samples ◽  
Severe Respiratory Infection ◽  
The Government

Background: A recent ongoing pandemic of coronavirus disease named coronavirus disease 2019 (COVID-19) has spread in Syria from March 2020 with a pattern of a slow case increase. So far, the government has put the country under lock-down orders as a preventive measure. However, there is a considerable belief in the medical community of our country supposes that the virus has previously passed through the country depending on the high numbers of diagnosed severe respiratory infections early in 2020. Thus, this study was designed to determine the number of people with detectable antibodies to SARS-CoV-2 from two samples of healthy adults with and without a previous history of severe respiratory infection in the last 6 months of the study. Materials and Methods: To this end, samples were collected from 123 and 198 subjects with a previous severe respiratory infection and healthy controls, respectively. Then, immunoglobulin M (IgM) and IgG anti-SARS-CoV-2 antibodies were tested as well. Results: None of the samples from both groups tested IgG positive in the assay while four tested IgM samples were positive. Accordingly, these positive samples were re-analyzed and remained IgM positive in the second test although the reverse transcriptase-polymerase chain reaction for the SARS-CoV-2 virus was negative. Conclusion: Based on our findings, there is no evidence concerning the previous COVID-19 infection in Syria thus it is suggested that all isolation and lock-down orders should be respected as an effective preventive tool in this regard.

CLINICO-PATHOLOGIC CONFERENCE: 18-MONTH-OLD BOY WITH FEVER AND SEVERE RESPIRATORY INFECTION

2002 ◽  
Vol 21 (5) ◽  
pp. 491-506
Author(s):  
William F. Pomputius ◽  
Atilano Lacson ◽  
Herbert H. Pomerance
Keyword(s):  
Respiratory Infection ◽  
Severe Respiratory Infection

Familial susceptibility to severe respiratory infection in early life

2004 ◽  
Author(s):  
Tessa Goetghebuer ◽  
Dominic Kwiatkowski ◽  
Anne Thomson ◽  
Jeremy Hull
Keyword(s):  
Respiratory Infection ◽  
Early Life ◽  
Severe Respiratory Infection

Familial susceptibility to severe respiratory infection in early life

2004 ◽  
Vol 38 (4) ◽  
pp. 321-328 ◽  
Author(s):  
Tessa Goetghebuer ◽  
Dominic Kwiatkowski ◽  
Anne Thomson ◽  
Jeremy Hull
Keyword(s):  
Respiratory Infection ◽  
Early Life ◽  
Severe Respiratory Infection

scholarly journals Prison and community outbreak of severe respiratory infection due to adenovirus type 14p1 in Tayside, UK

2014 ◽  
Vol 37 (1) ◽  
pp. 64-69 ◽  
Author(s):  
B. J. Parcell ◽  
P. G. McIntyre ◽  
D. L. Yirrell ◽  
A. Fraser ◽  
M. Quinn ◽  
...  
Keyword(s):  
Respiratory Infection ◽  
Adenovirus Type ◽  
Severe Respiratory Infection

scholarly journals Human Adenovirus Associated with Severe Respiratory Infection, Oregon, USA, 2013–2014

2016 ◽  
Vol 22 (6) ◽  
pp. 1044-1051 ◽  
Author(s):  
Magdalena Kendall Scott ◽  
Christina Chommanard ◽  
Xiaoyan Lu ◽  
Dianna Appelgate ◽  
LaDonna Grenz ◽  
...  
Keyword(s):  
Respiratory Infection ◽  
Human Adenovirus ◽  
Severe Respiratory Infection

scholarly journals Identification and Epidemiology of Severe Respiratory Disease due to Novel Swine-Origin Influenza A (H1N1) Virus Infection in Alberta

2010 ◽  
Vol 21 (4) ◽  
pp. e151-e157
Author(s):  
George Zahariadis ◽  
Ari R Joffe ◽  
James Talbot ◽  
Albert deVilliers ◽  
Patricia Campbell ◽  
...  
Keyword(s):  
United States ◽  
Respiratory Infection ◽  
Influenza A ◽  
Respiratory Illness ◽  
The United States ◽  
Molecular Methods ◽  
Contact Tracing ◽  
Severe Respiratory Distress ◽  
Influenza A H1n1 ◽  
Severe Respiratory Infection

BACKGROUND: In March 2009, global surveillance started detecting cases of influenza-like illness in Mexico. By mid-April 2009, two pediatric patients were identified in the United States who were confirmed to be infected by a novel influenza A (H1N1) strain. The present article describes the first identified severe respiratory infection and the first death associated with pandemic H1N1 (pH1N1) in Canada.METHODS: Enhanced public health and laboratory surveillance for pH1N1 was implemented throughout Alberta on April 24, 2009. Respiratory specimens from all patients with a respiratory illness and travel history or those presenting with a severe respiratory infection requiring hospitalization underwent screening for respiratory viruses using molecular methods. For the first severe case identified and the first death due to pH1N1, histocompatibility leukocyte antigens were compared by molecular methods.RESULTS: The first death (a 39-year-old woman) occurred on April 28, 2009, and on May 1, 2009, a 10-year-old child presented with severe respiratory distress due to pH1N1. Both patients had no travel or contact with anyone who had travelled to Mexico; the cases were not linked. Histocompatibility antigen comparison of both patients did not identify any notable similarity. pH1N1 strains identified in Alberta did not differ from the Mexican strain.CONCLUSION: Rapid transmission of pH1N1 continued to occur in Alberta following the first death and the first severe respiratory infection in Canada, which were identified without any apparent connection to Mexico or the United States. Contact tracing follow-up suggested that oseltamivir may have prevented ongoing transmission of pH1N1.

scholarly journals Lessons learned from COVID-19 outbreaks profile in combination with pathology, diagnosis, treatment and vaccines

2021 ◽  
Vol 292 ◽  
pp. 03069
Author(s):  
Ruizhe Liu ◽  
Enqi Zhang
Keyword(s):  
Public Health ◽  
Infectious Disease ◽  
Disease Control ◽  
Respiratory Infection ◽  
Surveillance System ◽  
Lessons Learned ◽  
Chinese Government ◽  
Basic Information ◽  
Health It ◽  
Severe Respiratory Infection

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which may lead to severe respiratory infection. Since December 2019, the first COVID-19 case was detected in Wuhan, Hubei Province, China. The virus has been spread worldwide, and many countries are still struggling with disease control. Therefore, this revision would provide experience accumulated and the lessons learned by China in the pandemic. The current work reviewed the basic information about COVID-19 in the aspects of pathology, diagnosis, treatment, prevention, and the major pandemic outbreaks in China. By summarizing and analyzing the measurements taken by the Chinese government and their corresponding outcomes on public health, it determined the progress made on the policies and their efficiency in the control of pandemics. With the sharing of these lessons, other countries can learn from establishing the COVID-19 surveillance system in China that would support their struggle on domestic public health.

Common variable hypogammaglobulinemia and severe respiratory infection by influenza B virus in pediatric patient

2002 ◽  
Vol 109 (1) ◽  
pp. S197-S197 ◽  
Author(s):  
Cristina Jacob ◽  
Angela Fomin ◽  
Ana Paula Castro ◽  
Renata Santoro ◽  
Jacques Sztajnbok ◽  
...  
Keyword(s):  
Pediatric Patient ◽  
Respiratory Infection ◽  
Influenza B Virus ◽  
Influenza B ◽  
B Virus ◽  
Severe Respiratory Infection ◽  
Common Variable

scholarly journals Treatment of COVID-19 patients using plasma therapy: Letter to Editor

2020 ◽  
pp. 84-87
Keyword(s):  
Side Effects ◽  
Respiratory Infection ◽  
Therapeutic Approach ◽  
Population Studies ◽  
Specific Drug ◽  
Plasma Therapy ◽  
Severe Respiratory Infection

The symptoms of COVID-19, caused by the newly known type of coronavirus, vary widely from asymptomatic, mild to severe respiratory infection leading to hospitalization or death of patients. To date, no specific drug has been reported for the treatment of patients affected by this virus. One of the approaches adopted for the treatment of this disease is the use of plasma therapy, which contains antibodies against the virus. Following of the plasma therapy have not been reported any serious side effects. Currently, the numbers of these studies are limited, and evaluation of the larger population studies can provide stronger evidence for treating physicians about the effectiveness of this therapeutic approach.

Sign in / Sign up

Export Citation Format

Share Document